Cambridge, MA
Obsidian Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops adoptive cell therapies for the treatment of patient with cancer diseases. Obsidian Therapeutics serves customers in the State of Massachusetts.
obsidiantx.comThese are collections Obsidian Therapeutics is a part of. Click on the collection name to view similar companies.
Series C
$160,500,000
Series B
$115,000,000
Series A
$49,500,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Obsidian Therapeutics.